310 related articles for article (PubMed ID: 34381458)
1. Type I Interferon Induction in Cutaneous DNA Damage Syndromes.
Klein B; Günther C
Front Immunol; 2021; 12():715723. PubMed ID: 34381458
[TBL] [Abstract][Full Text] [Related]
2. Type I interferonopathies--an expanding disease spectrum of immunodysregulation.
Lee-Kirsch MA; Wolf C; Kretschmer S; Roers A
Semin Immunopathol; 2015 Jul; 37(4):349-57. PubMed ID: 25998914
[TBL] [Abstract][Full Text] [Related]
3. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
Jiang J; Zhao M; Chang C; Wu H; Lu Q
Clin Rev Allergy Immunol; 2020 Oct; 59(2):248-272. PubMed ID: 32557263
[TBL] [Abstract][Full Text] [Related]
4. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
Günther C; Schmidt F; König N; Lee-Kirsch MA
Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon-mediated autoinflammation and autoimmunity.
Kretschmer S; Lee-Kirsch MA
Curr Opin Immunol; 2017 Dec; 49():96-102. PubMed ID: 29128691
[TBL] [Abstract][Full Text] [Related]
6. The Type I Interferonopathies.
Lee-Kirsch MA
Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
[TBL] [Abstract][Full Text] [Related]
7. [Ocular manifestations in hereditary diseases with defects in DNA repair].
Woźniak K; Kuc D; Błasiak J; Kurowska AK; Szaflik J; Szaflik JP
Klin Oczna; 2014; 116(2):142-5. PubMed ID: 25345296
[TBL] [Abstract][Full Text] [Related]
8. Progeroid syndromes and UV-induced oxidative DNA damage.
Kamenisch Y; Berneburg M
J Investig Dermatol Symp Proc; 2009 Aug; 14(1):8-14. PubMed ID: 19675546
[TBL] [Abstract][Full Text] [Related]
9. Ocular manifestations in the inherited DNA repair disorders.
Dollfus H; Porto F; Caussade P; Speeg-Schatz C; Sahel J; Grosshans E; Flament J; Sarasin A
Surv Ophthalmol; 2003; 48(1):107-22. PubMed ID: 12559331
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Approaches to Type I Interferonopathies.
Bienias M; Brück N; Griep C; Wolf C; Kretschmer S; Kind B; Tüngler V; Berner R; Lee-Kirsch MA
Curr Rheumatol Rep; 2018 Apr; 20(6):32. PubMed ID: 29679241
[TBL] [Abstract][Full Text] [Related]
11. The role of nucleic acid sensors and type I IFNs in patient populations and animal models of autoinflammation.
Nündel K; Marshak-Rothstein A
Curr Opin Immunol; 2019 Dec; 61():74-79. PubMed ID: 31569013
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease.
Lepelley A; Wai T; Crow YJ
Front Immunol; 2021; 12():729763. PubMed ID: 34512665
[TBL] [Abstract][Full Text] [Related]
13. DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity.
Manolakou T; Verginis P; Boumpas DT
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072535
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
Front Immunol; 2021; 12():713779. PubMed ID: 34367181
[TBL] [Abstract][Full Text] [Related]
15. Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.
Kim H; Sanchez GA; Goldbach-Mansky R
J Mol Med (Berl); 2016 Oct; 94(10):1111-1127. PubMed ID: 27678529
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.
Hsiao HB; Chou AH; Lin SI; Chen IH; Lien SP; Liu CC; Chong P; Liu SJ
J Virol; 2014 Oct; 88(20):11658-70. PubMed ID: 25078697
[TBL] [Abstract][Full Text] [Related]
17. Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts.
Duan X; Ponomareva L; Veeranki S; Panchanathan R; Dickerson E; Choubey D
Mol Cancer Res; 2011 May; 9(5):589-602. PubMed ID: 21471287
[TBL] [Abstract][Full Text] [Related]
18. Understanding photodermatoses associated with defective DNA repair: Syndromes with cancer predisposition.
Giordano CN; Yew YW; Spivak G; Lim HW
J Am Acad Dermatol; 2016 Nov; 75(5):855-870. PubMed ID: 27745641
[TBL] [Abstract][Full Text] [Related]
19. Does type-I interferon drive systemic autoimmunity?
Picard C; Belot A
Autoimmun Rev; 2017 Sep; 16(9):897-902. PubMed ID: 28694138
[TBL] [Abstract][Full Text] [Related]
20. Regulation of type I interferon responses.
Ivashkiv LB; Donlin LT
Nat Rev Immunol; 2014 Jan; 14(1):36-49. PubMed ID: 24362405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
